Shionogi Announces Appointment of Corporate officers, the Establishment of new Organization and Personnel Reassignment (Effective April 1, Jun 18, and July 1, 2025)

OSAKA, Japan, March 24, 2025 - Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “SHIONOGI”) announces that the appointment of corporate officers will take effect on April 1, 2025. And it will implement the following new establishment of new organization and personnel reassignment, effective June 18 and July 1. 2025.

1. Appointment of Corporate Officers (Effective; April 1,2025)

Name	New Position	Present Position
Toshiyuki Asaki	Corporate Officer, Senior Vice President, Drug Discovery Research Division	President, Shionogi Techno Advance Research Co., Ltd.
Masako Kudo	Corporate Officer, Senior Vice President, Corporate Strategy Division	Vice President, Finance & Accounting Department
Kenji Matsuo	Corporate Officer, Vice President, Internal Control Department	Vice President, Internal Control Department

2. Establishment of new Organization (Effective; Jun 18, 2025)

· In conjunction with the transition to a company with an Audit and Supervisory Committee, a new "Audit and Supervisory Committee Office" will be established directly under the Audit and Supervisory Committee.

3. Personnel Reassignments (Effective; Jun 18, 2025)

Name	New Position	Present Position
Kyoko Nagao	Vice President, Audit and Supervisory Committee Office	Internal Control Department

4. Personnel Reassignments (Effective; July 1, 2025)

Name	New Position	Present Position
R&D Supervisory Unit
John Keller	Senior Executive Officer, Senior Vice President, R&D Supervisory Unit	Senior Executive Officer, Senior Vice President, R&D Supervisory Unit and Pharmaceutical Technology Research Division
Pharmaceutical Technology Research Division
Tatsumori Yoshida	Corporate Officer, Senior Vice President, Pharmaceutical Technology Research Division	Corporate Officer, Chairman and CEO of Ping An Shionogi Company Ltd. and Shionogi (Hong Kong) Commerce Ltd.
Healthcare Business Supervisory Unit
[Ping An Shionogi Company Ltd.]
Hirofumi Nagatome	Chairman and CEO	Healthcare Business Supervisory Unit Office
[Shionogi (Hong Kong) Commerce Ltd.]
Hirofumi Nagatome	Chairman and CEO	Healthcare Business Supervisory Unit Office

For Further Information, Contact:

SHIONOGI Website Inquiry Form:

https://www.shionogi.com/global/en/contact.html

PDF